| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FNDC3B_0013800 | Exon-Exon | chr3:171944661-172070873 | chr3:172226871-172353083 | 83 nt | 0.5060 |
| hsa_FNDC3B_0013200 | Exon-Exon | chr3:171944661-172080635 | chr3:172226871-172362845 | 2821 nt | 0.4942 |
| hsa_FNDC3B_0013900 | Exon-Exon | chr3:171944661-172098883 | chr3:172226871-172381093 | 321 nt | 0.5109 |
| hsa_FNDC3B_0014000 | Exon-Exon | chr3:171944661-172115282 | chr3:172226871-172397492 | 128 nt | 0.4063 |
| hsa_FNDC3B_0014100 | Intron-Intron | chr3:171944794-171946258 | chr3:172227004-172228468 | 1465 nt | 0.3720 |
| hsa_chr3_0366900 | Intergenic-Intergenic | chr3:171948784-171948957 | chr3:172230994-172231167 | 174 nt | 0.3391 |
| hsa_FNDC3B_0014200 | Intron-Intron | chr3:171949949-171952003 | chr3:172232159-172234213 | 2055 nt | 0.3815 |
| hsa_FNDC3B_0014300 | Intron-Intron | chr3:171951633-171951793 | chr3:172233843-172234003 | 161 nt | 0.3602 |
| hsa_FNDC3B_0014400 | Intron-Exon-Intron | chr3:171953486-171969331 | chr3:172235696-172251541 | 250 nt | 0.3760 |
| hsa_FNDC3B_0014500 | Intron-Exon-Intron | chr3:171954052-171969331 | chr3:172236262-172251541 | 250 nt | 0.3840 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].